Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A.

The American journal of cardiology - 1 Apr 2001

Piippo K, Holmström S, Swan H, Viitasalo M, Raatikka M, Toivonen L, Kontula K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimalarials
Share to Electrocardiography
Share to Long QT Syndrome
Share to NAV1.5 Voltage-Gated Sodium Channel

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pedigree

Share to Phenanthrenes

Share to Sodium Channels

Share to Tachycardia, Ventricular

Source

Identifiers

PMID: 11274952
DOI: 10.1016/s0002-9149(00)01538-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A.PMID 11274952Read ↗

Flecainide, a therapeutic option in a patient with long QT syndrome type 3 caused by the heterozygous V411M mutation in the SCN5A gene.Semantic proximity Read ↗

Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical EvaluationSemantic proximity Read ↗

Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy.Semantic proximity Read ↗

Voltage Gated Sodium Channel Genes in Epilepsy: Mutations, Functional Studies, and Treatment DimensionsSemantic proximity Read ↗

The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology.Semantic proximity Read ↗

The cardiac sodium channel: gating function and molecular pharmacology.Semantic proximity Read ↗

Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.Semantic proximity Read ↗

Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.